SCHEMBL6186718

SCHEMBL6186718

O=C(O)Cc1cc(F)ccc1[N+](=O)[O-].O=C(O)Cc1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SNCA P37840 5/20 0.50
CYP1A2 P05177 1/20 0.46
IDO1 P14902 1/20 0.44
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.40
FBP1 P09467 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396060 0.89 CYP1A2 (0.55) SNCACYP1A2ATMTDP1MAPT
SCHEMBL7418264 0.81 CYP1A2 (0.57) SNCACYP1A2TDP1MAPTALDH1A1
SCHEMBL9113 0.80 AKR1B1 (0.58) CYP1A2TDP1MAPTKDM4E
Hydrochloric Acid SCHEMBL2531929 0.78 AKR1B1 (0.56) CYP1A2IDO1
SCHEMBL2989578 0.77 CYP1A2 (0.69) SNCACYP1A2ATMTDP1MAPT
SCHEMBL2989584 0.77 CYP1A2 (0.69) SNCACYP1A2ATMTDP1MAPT
SCHEMBL9651648 0.77 MAOA (0.59) SNCAATMTDP1MAPTALDH1A1
SCHEMBL20616356 0.76 AKR1B1 (0.64) CYP1A2TDP1MAPTKDM4EHTT
SCHEMBL23200508 0.76 ATM (0.51) SNCACYP1A2ATMTDP1MAPT
SCHEMBL10509624 0.76 TDP1 (0.51) SNCACYP1A2IDO1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546145-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2005-06-29 EP disclosed
WO-2004029048-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2004-04-08 WO disclosed